Oral semaglutide reduces appetite and energy intake and improves control of eating in subjects with type 2 diabetes

Blundell, J orcid.org/0000-0002-7085-9596, Gibbons, C, Hoff, ST et al. (3 more authors) (2019) Oral semaglutide reduces appetite and energy intake and improves control of eating in subjects with type 2 diabetes. In: 55th EASD Annual Meeting of the European Association for the Study of Diabetes, 16-20 Sep 2019, Barcelona.

Metadata

Authors/Creators:
Dates:
  • Published: September 2019
Institution: The University of Leeds
Academic Units: The University of Leeds > Faculty of Medicine and Health (Leeds) > School of Psychology (Leeds)
Depositing User: Symplectic Publications
Date Deposited: 06 Jan 2021 14:49
Last Modified: 06 Jan 2021 14:49
Status: Published
Identification Number: https://doi.org/10.1007/s00125-019-4946-6
Related URLs:

Download not available

A full text copy of this item is not currently available from White Rose Research Online

Export

Statistics


CORE (COnnecting REpositories)